Griffiths, Joshua https://orcid.org/0000-0001-6429-8131
Mills, Mark T
Ong, Albert CM https://orcid.org/0000-0002-7211-5400
Clinical trials referenced in this document:
Documents that mention this clinical trial
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
https://doi.org/10.2215/cjn.03960318
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement
https://doi.org/10.2215/cjn.13661119
Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
https://doi.org/10.1136/bmjopen-2019-032620
Documents that mention this clinical trial
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
https://doi.org/10.2215/cjn.03960318
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement
https://doi.org/10.2215/cjn.13661119
Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
https://doi.org/10.1136/bmjopen-2019-032620